The Effect of Xmn -1 Polymorphism and Coinheritance of Alpha Mutations on Age at First Blood Transfusion in Iranian Patients with Homozygote IVSI-5 Mutation
- PMID: 35975115
- PMCID: PMC9339124
- DOI: 10.18502/ijhoscr.v16i1.8441
The Effect of Xmn -1 Polymorphism and Coinheritance of Alpha Mutations on Age at First Blood Transfusion in Iranian Patients with Homozygote IVSI-5 Mutation
Abstract
Background : Thalassemia syndromes are the most prevalent hereditary hemoglobinopathies in the world. Iran is located on the thalassemia belt. In this study, the effect of Xmn -1 polymorphism and coinheritance of alpha mutations on age at first transfusion and also transfusion interval in Iranian thalassemic patients with homozygous IVSI-5 mutation were assessed. Materials and Methods : In this retrospective cross-sectional study 154 transfusion dependent thalassemia (TDT) patients (140 patients with β-thalassemia major and 14 cases with β-thalassemia intermedia) who were homozygote of IVSI-5 mutation have been participated. Blood samples were collected from participants using EDTA containers for genomic DNA analysis. DNA extraction and amplification-refractory mutation to determine the Xmn -1 polymorphism were performed. Multiplex PCR was performed to identify alpha globin deletions. Results: The mean age of participants was 29±7, 58 of them were male and 96 were female. A significant relation between presence of Xmn -1 polymorphism and age at receiving first transfusion was detected. Coinheritance of alpha thalassemia mutation does not have significant effect on age at first transfusion or transfusion interval. Conclusion : Presence of Xmn -1 polymorphism can delay the onset of transfusion in patients with homozygote IVSI-5 mutation.
Keywords: Mutation; Thalassemia; Transfusion; XmN-1 polymorphism.
Copyright © 2022 Tehran University of Medical Sciences.
Similar articles
-
Laboratory diagnosis for thalassemia intermedia: Are we there yet?J Clin Lab Anal. 2019 Jan;33(1):e22647. doi: 10.1002/jcla.22647. Epub 2018 Sep 17. J Clin Lab Anal. 2019. PMID: 30221402 Free PMC article.
-
Beta-thalassemia intermedia from southern Iran: IVS-II-1 (G-->A) is the prevalent thalassemia intermedia allele.Hemoglobin. 2002 May;26(2):147-54. doi: 10.1081/hem-120005452. Hemoglobin. 2002. PMID: 12144057
-
Xmn1-158 γGVariant in B-Thalassemia Intermediate Patients in South-East of Iran.Int J Hematol Oncol Stem Cell Res. 2017 Apr 1;11(2):165-171. Int J Hematol Oncol Stem Cell Res. 2017. PMID: 28875012 Free PMC article.
-
Genetic factors affecting clinical severity in beta-thalassemia syndromes.J Pediatr Hematol Oncol. 2000 Nov-Dec;22(6):573-80. doi: 10.1097/00043426-200011000-00026. J Pediatr Hematol Oncol. 2000. PMID: 11132233 Review.
-
Molecular basis of asymptomatic beta-thalassemia major in an African American individual.Am J Med Genet. 1997 Mar 17;69(2):196-9. Am J Med Genet. 1997. PMID: 9056561 Review.
References
-
- Cappellini MD, Viprakasit V, Taher AT. An overview of current treatment strategies for β-thalassemia. Expert Opin Orphan Drugs. 2014;2(7):665–79.
-
- Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001;25(3):285–96. - PubMed
-
- Bazi A, Miri-Moghaddam E. Spectrum of β-thalassemia Mutations in Iran, an Update. Iran J Ped Hematol Oncol. 2016;6(3):190–202.
LinkOut - more resources
Full Text Sources